Beacon Biosignals
Beacon Biosignals is dedicated to transforming brain health through AI-driven neurotechnology. Their mission is to accelerate innovation and bring life-changing treatments to patients faster by leveraging advanced EEG technology, machine learning, and clinical research expertise. They develop scalable, FDA-cleared brain monitoring devices and platforms that support clinical trials, research, and clinical practice, aiming to improve diagnosis, treatment, and understanding of neurological, psychiatric, and sleep disorders.
Industries
Nr. of Employees
medium (51-250)
Products
FDA‑cleared wearable EEG headband
A multi‑channel, at‑home wearable EEG device engineered to capture PSG‑quality EEG and related signals (accelerometry), store raw EDF data, and support overnight and daytime recordings.
Cloud biosignal datastore
Central, version‑controlled data platform for storing, integrating, and analyzing large volumes of biosignal data with secure backups and access controls.
Clinical analytics portal
Web portal for visualizing EEG datasets, interrogating cohorts, monitoring trial sites, and exporting datasets for downstream analysis or regulatory submission.
Mobile companion application
Patient‑facing mobile application to pair with the wearable device, guide setup, capture patient‑initiated recordings, and collect customizable questionnaires in multiple languages.
FDA‑cleared wearable EEG headband
A multi‑channel, at‑home wearable EEG device engineered to capture PSG‑quality EEG and related signals (accelerometry), store raw EDF data, and support overnight and daytime recordings.
Cloud biosignal datastore
Central, version‑controlled data platform for storing, integrating, and analyzing large volumes of biosignal data with secure backups and access controls.
Clinical analytics portal
Web portal for visualizing EEG datasets, interrogating cohorts, monitoring trial sites, and exporting datasets for downstream analysis or regulatory submission.
Mobile companion application
Patient‑facing mobile application to pair with the wearable device, guide setup, capture patient‑initiated recordings, and collect customizable questionnaires in multiple languages.
Services
Operational delivery for clinical trials including device provisioning, logistics, site and user training, continuous data quality monitoring, and protocol compliance oversight.
Advisory and analytic services covering trial design, biomarker discovery, translational interpretation, statistical reporting, and regulatory‑ready deliverables.
In‑kind support program for academic investigators providing devices, analytics access, and operational assistance to enable sleep and neuroscience research.
Operational delivery for clinical trials including device provisioning, logistics, site and user training, continuous data quality monitoring, and protocol compliance oversight.
Advisory and analytic services covering trial design, biomarker discovery, translational interpretation, statistical reporting, and regulatory‑ready deliverables.
In‑kind support program for academic investigators providing devices, analytics access, and operational assistance to enable sleep and neuroscience research.
Expertise Areas
- Clinical trial management for neurology and psychiatry
- Sleep EEG biomarker discovery
- Biosignal machine learning and analytics
- Wearable medical device engineering
Key Technologies
- Electroencephalography (EEG)
- Automated sleep staging algorithms
- Machine learning / AI for biosignals
- Cloud‑based datastore and analytics
News & Updates
Beacon Biosignals announced the acquisition of CleveMed, expanding their capabilities in neurotechnology.
The FDA approval supports continuous algorithm enhancements in sleep monitoring.
A peer-reviewed study demonstrating the accuracy of Beacon’s sleep monitoring technology.
Research on EEG spectral abnormalities in a neurological disorder.
FDA Clearance for Sleep Monitoring Device Dreem 3S
Beacon received FDA clearance for their AI-assisted sleep monitoring device, now called Waveband.
Peer-reviewed validation of Waveband's sleep staging accuracy
Independent study published in Sleep journal confirms Waveband's measurement accuracy comparable to PSG.
Beacon Biosignals announced the acquisition of CleveMed, expanding their capabilities in neurotechnology.
The FDA approval supports continuous algorithm enhancements in sleep monitoring.
A peer-reviewed study demonstrating the accuracy of Beacon’s sleep monitoring technology.
Research on EEG spectral abnormalities in a neurological disorder.
FDA Clearance for Sleep Monitoring Device Dreem 3S
Beacon received FDA clearance for their AI-assisted sleep monitoring device, now called Waveband.
Peer-reviewed validation of Waveband's sleep staging accuracy
Independent study published in Sleep journal confirms Waveband's measurement accuracy comparable to PSG.